Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03927768 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP)

StatusActive, Not Recruiting
PhaseNot specified
Started2018-07-31
View on ClinicalTrials.gov ↗

Amendment history

2026-09-25
Completion pushed: 2026-08-31 → 2027-04-25
2025-10-29
Study Status v9
Completion date2025-08-31→2026-08-31
2024-12-16
Study Status v8
Re-verified, no change to tracked fields
2024-01-02
Study Status v7
Primary completion dateestimated 2023-10-23→confirmed 2023-08-31
Completion date2023-10-23→2025-08-31
2023-02-03
Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v6
Trial statusRecruiting→Active, Not Recruiting
Primary completion date2022-12-31→2023-10-23
Completion date2023-06-30→2023-10-23
Enrollment targetestimated 200→confirmed 264
Study sitesdetails revised at 1 of 1 site
Show 5 earlier versions
2022-08-05
Study Status v5
Primary completion date2022-06-30→2022-12-31
Completion date2022-06-30→2023-06-30
2022-05-03
Study Status v4
Primary completion date2022-03→2022-06-30
Completion date2022-03→2022-06-30
2021-06-09
Study Status v3
Primary completion date2020-12→2022-03
Completion date2020-12→2022-03
2020-07-24
Study Status, Contacts/Locations, IPDSharing v2
Study sitescontacts updated at 1 of 1 site
2020-02-27
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2024-01→2020-12
Completion date2024-01→2020-12
Start dateestimated 2019-06→confirmed 2018-07-31
Study sitesdetails revised at 1 of 1 site
2019-04-23
Original filing
The purpose of this study is to use a magnetic resonance imaging (MRI) sequence called golden-angle radial compressed sensing and parallel imaging (GRASP) as a noninvasive and fast way to measure the wash-in contrast (dye) in the breast. MRI uses a strong magnetic field and radio waves to create images of structures in the body. The goal is to determine if benign and malignant breast lesions have different patterns of contrast wash in. This study will ask woman planning to undergo a clinical breast MRI with contrast (dye) as part of their standard care.
Trial Details
NCT Number NCT03927768
Lead Sponsor NYU Langone Health
Conditions Breast Cancer
Enrollment 264 participants
Start Date 2018-07-31
Primary Completion 2023-08-31 (estimated)
Study Completion 2027-04-25 (estimated)
Updated on ClinicalTrials.gov 2026-09-24